Cargando…

Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection

Herein, we describe three patients affected by metastatic colorectal cancer (mCRC) experiencing infection by severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) and reduction of disease burden during coronavirus disease 2019 (COVID-19) course. Insights into tumor-associated angiotensin-conv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ottaiano, Alessandro, Scala, Stefania, D’Alterio, Crescenzo, Trotta, Annamaria, Bello, Annamaria, Rea, Giuseppina, Picone, Carmine, Santorsola, Mariachiara, Petrillo, Antonella, Nasti, Guglielmo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107669/ https://www.ncbi.nlm.nih.gov/pubmed/33995596 http://dx.doi.org/10.1177/17588359211011455

Ejemplares similares

Prognostic Significance of CXCR4 in Colorectal Cancer: An Updated Meta-Analysis and Critical Appraisal
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

A New Source of Heterogeneity in Comparative and Translational Clinical Trials: The “Border-Time” Bias
por: Santorsola, Mariachiara, et al.
Publicado: (2022)

Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
por: D’Alterio, Crescenzo, et al.
Publicado: (2020)

Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review
por: Santorsola, Mariachiara, et al.
Publicado: (2022)

Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity
por: Trotta, Anna Maria, et al.
Publicado: (2018)

KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

COVID-19 Outbreak: The North versus South Epidemiologic Italian Paradigm
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology
por: Capuozzo, Maurizio, et al.
Publicado: (2022)

Prediction of response to anti-EGFR antibodies in metastatic colorectal cancer: looking beyond EGFR inhibition
por: Ottaiano, Alessandro, et al.
Publicado: (2013)

Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Characterization of KRAS Mutational Regression in Oligometastatic Patients
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol
por: Ottaiano, Alessandro, et al.
Publicado: (2019)

Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types
por: Scognamiglio, Giosuè, et al.
Publicado: (2016)

p53: From Fundamental Biology to Clinical Applications in Cancer
por: Capuozzo, Maurizio, et al.
Publicado: (2022)

Multifaceted Insights into Innovative Approaches to Treating Colorectal Cancer Metastasis: From Emerging Biological Factors to Radiomics
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Peripheral myeloid-derived suppressor and T regulatory PD-1 positive cells predict response to neoadjuvant short-course radiotherapy in rectal cancer patients
por: Napolitano, Maria, et al.
Publicado: (2015)

From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells
por: Ieranò, Caterina, et al.
Publicado: (2019)

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Non-invasive prenatal testing can detect silent cancers in expecting mothers
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors
por: Capuozzo, Maurizio, et al.
Publicado: (2023)

New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM
por: Scala, Stefania, et al.
Publicado: (2020)

Effect of Octreotide Long-Acting Release on Tregs and MDSC Cells in Neuroendocrine Tumour Patients: A Pivotal Prospective Study
por: von Arx, Claudia, et al.
Publicado: (2020)

Fc gamma receptor IIIa polymorphisms in advanced colorectal cancer patients correlated with response to anti-EGFR antibodies and clinical outcome
por: Calemma, Rosa, et al.
Publicado: (2012)

Circulating Vitamin D Level and Its Impact on Mortality and Recurrence in Stage III Colorectal Cancer Patients: A Systematic Review and Meta-Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Inhibition of stromal CXCR4 impairs development of lung metastases
por: D’Alterio, Crescenzo, et al.
Publicado: (2012)

A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors
por: Santagata, Sara, et al.
Publicado: (2017)

CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
por: Neve Polimeno, Maria, et al.
Publicado: (2015)

Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice
por: Ottaiano, Alessandro, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_v28ok5k3fdvl5dttv4bto5leqb